Wealth Enhancement Trust Services’s Usana Health Sciences USNA Stock Holding History

Wealth Enhancement Trust Services’s Portfolio USNA Stock Details USNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$406	Buy	+19	New	+$357	﹤0.01%	1274

Other funds holding USNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Wealth Enhancement Trust Services's USNA Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Usana Health Sciences (USNA) in Q2 2026: 19 shares worth $406. The stake represents ﹤0.01% of the portfolio and ranks #1274 among its holdings.

71 funds tracked by Wall St. Rank hold USNA as of Q2 2026.

Wealth Enhancement Trust Services held 19 shares of Usana Health Sciences worth $406 as of Q2 2026.
Usana Health Sciences was a new Wealth Enhancement Trust Services position in Q2 2026.
Usana Health Sciences made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #1274 holding.
71 funds tracked by Wall St. Rank held Usana Health Sciences as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.